Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Goodman Corey S
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   12,296,786    

Indirect Shares

   8,829,949      
Direct Value   $343,454,843    

Indirect Value

   $60,562,155      
Total Shares   21,126,735      
Total Value   $404,016,998      


Pfizer Inc $2,434,067 Metacrine, Inc. $0 Ventyx Biosciences, Inc. $18,687,233 Rayzebio, Inc. $322,333,543 Pfizer Inc $2,434,067 Metacrine, Inc. $0 Ventyx Biosciences, Inc. $18,687,233 Rayzebio, Inc. $322,333,543
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   0.0   
     Percentage Gain/Loss :
   -27.8%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Renovis Inc RNVS Director 2008-05-02 0 2008-05-02 0    Premium*  
            Pfizer Inc PFE Senior Vice President 2009-02-26 82,232 2009-02-26 1,095    Premium*  
            Precision Biosciences Inc DTIL 10% Owner 2019-04-01 0 2019-04-01 4,265,141    Premium*  
            Akero Therapeutics, Inc. AKRO 2019-06-24 0 2020-07-06 3,033,552    Premium*  
            Alx Oncology Holdings Inc ALXO Executive Chairman, Di... 0 2020-07-21 515,894    Premium*  
            Metacrine, Inc. MTCR 2020-09-18 3,059,123 2020-09-18 0    Premium*  
            Ventyx Biosciences, Inc. VTYX See Remarks, 10% Owner 2021-10-25 3,997,269 2021-10-25 1,014,267    Premium*  
            Rayzebio, Inc. RYZB 2023-09-19 5,158,162 2023-09-19 0    Premium*  
* Premium Members only  

Records found :    82         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RNVS Renovis Inc President and CEO   •       •      –    2006-03-01 4 AS $21.78 $197,683 I/I (9,000) 236,956 -
RNVS Renovis Inc President and CEO   •       •      –    2006-03-06 4 AS $21.91 $274,597 I/I (12,500) 224,456 -
RNVS Renovis Inc President and CEO   •       •      –    2006-04-03 4 AS $20.52 $186,962 I/I (9,000) 240,456 -
RNVS Renovis Inc President and CEO   •       •      –    2006-04-06 4 AS $20.12 $253,560 I/I (12,500) 227,956 -
RNVS Renovis Inc President and CEO   •       •      –    2006-05-01 4 AS $17.31 $105,406 I/I (6,000) 271,309 -
RNVS Renovis Inc President and CEO   •       •      –    2006-06-01 4 AS $16.14 $97,614 I/I (6,000) 265,309 -
RNVS Renovis Inc President and CEO   •       •      –    2006-07-03 4 AS $15.24 $91,966 I/I (6,000) 259,309 0 -
RNVS Renovis Inc President and CEO   •       •      –    2006-08-01 4 AS $12.11 $74,021 I/I (6,000) 253,309 -
RNVS Renovis Inc President and CEO   •       •      –    2006-09-01 4 AS $14.47 $88,448 I/I (6,000) 247,309 -
RNVS Renovis Inc President and CEO   •       •      –    2006-10-02 4 AS $13.50 $81,694 I/I (6,000) 241,309 0 -
RNVS Renovis Inc President and CEO   •       •      –    2006-10-26 4 AS $3.74 $93,530 I/I (25,000) 216,309 0 -
RNVS Renovis Inc President and CEO   •       •      –    2006-10-27 4 AS $3.52 $72,676 I/I (20,649) 195,660 0 -
RNVS Renovis Inc President and CEO   •       •      –    2006-11-20 4 AS $3.38 $6,262 I/I (1,852) 193,808 0 -
RNVS Renovis Inc President and CEO   •       •      –    2006-12-18 4 AS $3.09 $5,725 I/I (1,852) 191,956 0 -
DTIL Precision Biosciences Inc 10% Owner   –       –       •   2019-04-01 4 B $16.00 $800,000 I/I 50,000 50,000 1.5 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2019-06-24 4 B $16.00 $4,000,000 I/I 250,000 250,000 1.5 -
ALXO Alx Oncology Holdings Inc Executive Chairman   –       •       •   2020-07-21 4 B $19.00 $16,150,000 I/I 850,000 850,000 2.25 -
MTCR Metacrine, Inc. See Remarks   •       •       •   2020-09-18 4 B $13.00 $2,990,000 D/D 230,000 230,000 0.01 -
VTYX Ventyx Biosciences, Inc. See Remarks   –       –       •   2021-10-25 4 B $16.00 $5,000,000 D/D 312,500 3,997,269 2.45 %
RNVS Renovis Inc Director   –       •      –    2008-02-08 4 D $2.40 $91,745 D/D (38,227) 272,823 0 -
RNVS Renovis Inc Director   –       •      –    2008-05-02 4 D $0.00 $0 I/I (285,395) 0 0 -
RNVS Renovis Inc Director   –       •      –    2008-05-02 4 D $0.00 $0 D/D (272,823) 0 0 -
RNVS Renovis Inc President and CEO   •       •      –    2005-09-08 4 GD $0.00 $0 I/I 10,000 306,956 0 -
RNVS Renovis Inc President and CEOOfficer   •       •      –    2004-02-04 3 IO $0.00 $0 I/I 0 1,655,416 -
ALXO Alx Oncology Holdings Inc Director   –       •       •   2020-07-16 3 IO $0.00 $0 I/I 0 461,962 -
  82  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us